OncLive® Reveals the 2019 Innovative Technology in Cancer Care Challenge Finalists

The finalists will participate in a live final pitch-off to determine the first- and second-place winners

CRANBURY, N.J.--()--OncLive®, the nation’s leading multimedia resource focused on providing oncology professionals with the most current and insightful information they need to offer the best patient care, has named the six finalists of the OncLive® Innovation Challenge: Innovative Technology in Cancer Care. This challenge brings together great minds to discuss the potential of digital tools to change the way physicians approach health care at the individual and population levels.

“All six of these finalists have come up with extremely innovative ideas that could transform physicians’ clinical practice and patient outcomes,” said Michael J. Hennessy Jr., president and CEO of MJH Life Sciences™, parent company of OncLive®. “Each of them has presented a unique solution to a challenge in health care, and we can’t wait to see the first- and second-place winners declared during the webinar pitch-off.”

Selected by a panel of distinguished judges, the six finalists represent individuals in health care, including academic and community oncologists, managed care specialists, pharmacists and allied health professionals, who aim to fulfill unmet medical needs using current or future technology. Applicants were asked to submit concrete methods to combine current technology with oncology to create an innovative product designed to improve physicians’ clinical practice and/or patient outcomes.

The finalists for the 2019 Innovative Technology in Cancer Care Challenge are:

  • Rahul Banerjee, M.D., clinical fellow, division of hematology/oncology, department of medicine, University of California, San Francisco.
  • David Henderson, MBA, business analyst, clinical trials, Karmanos Cancer Institute.
  • Francesco Maura, M.D., myeloma service, department of medicine, Memorial Sloan Kettering Cancer Center.
  • Purandhri Pandya, senior consultant (life sciences), Navigant.
  • Aasim Sehbai, M.D., M.B.B.S., hematologist and oncologist, Alabama Cancer Care.
  • Juliet Wolford, M.D., M.S.-BATS, M.Arch., MLARP, fellow, division of gynecologic oncology, University of California.

“It is inspiring to see these six finalists create an idea that could change the way we approach health care,” said Robert Goldsmith, vice president of sales, MJH Life Sciences™. “We look forward to everyone coming together to meet these remarkable finalists and engage in collaborative challenges and innovative think tanks.”

The Innovative Technology in Cancer Care Challenge will host the final pitch-off on Saturday, Oct. 12. During this pitch-off, the six finalists will present their ideas virtually before a panel of distinguished judges. Two finalists will be chosen by the scores of the official judges. The first-place winner will receive $15,000, and the second-place winner will receive $7,500.

For more on their full submissions, click here.

About OncLive®

A digital platform of resources for practicing oncologists, OncLive® offers oncology professionals information they can use to help provide the best patient care. OncLive® is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in the U.S. dedicated to delivering trusted health care news across multiple channels.

Contacts

OncLive® Media Contact

John Patricolo, 609-325-4630
jpatricolo@mjhassoc.com

Release Summary

OncLive® Reveals the 2019 Innovative Technology in Cancer Care Challenge Finalists

Contacts

OncLive® Media Contact

John Patricolo, 609-325-4630
jpatricolo@mjhassoc.com